Long-Term Treatment of Chronic Hepatitis C with Glycyrrhizin [Stronger Neo-Minophagen C (SNMC)] for Preventing Liver Cirrhosis and Hepatocellular Carcinoma

Publisher： Karger

E-ISSN： 1423-0232|62|1|94-100

ISSN： 0030-2414

Source： Oncology, Vol.62, Iss.1, 2002-01, pp. : 94-100

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Long-Term Follow-Up of Chronic Hepatitis C Patients Treated with Interferon-Alpha: Risk of Cirrhosis and Hepatocellular Carcinoma in a Single Center over 10 Years

By  

Intervirology, Vol. 58, Iss. 1, 2015-01 ,pp. : 14-21

Karger

Access to resources Recommend Favorite

Interferon Reduces the Risk of Hepatocellular Carcinoma in Hepatitis C Virus-Related Chronic Hepatitis/Liver Cirrhosis

By  

Oncology, Vol. 78, Iss. 1, 2010-07 ,pp. : 17-23

Karger

Access to resources Recommend Favorite

Long-Term Outcome, with Monitoring of Platelet Counts, in Patients with Chronic Hepatitis C and Liver Cirrhosis after Interferon Therapy

By  

Intervirology, Vol. 46, Iss. 5, 2003-10 ,pp. : 296-307

Karger

Access to resources Recommend Favorite

Long-Term Outcomes of Hepatitis-C-Infected Patients Achieving a Sustained Virological Response and Undergoing Radical Treatment for Hepatocellular Carcinoma

By  

Oncology, Vol. 90, Iss. 3, 2016-02 ,pp. : 167-175

Karger

Access to resources Recommend Favorite

Interferon‐free therapy of chronic hepatitis C with direct‐acting antivirals does not change the short‐term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 47, Iss. 4, 2018-02 ,pp. : 516-525

John Wiley & Sons Inc

Access to resources Recommend Favorite